Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / July / Who Gets Access to Diagnostics
Infectious Disease Point of care testing Screening and monitoring Technology and innovation Research and Innovations

Who Gets Access to Diagnostics?

Designing low-cost pathogen detection tools for healthcare systems with limited resources

By Jessica Allerton 07/09/2026 Discussion 3 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Poll
  • Top Institutions

Share

Objective:

To discuss the development of a low-cost, portable diagnostic platform for detecting antimicrobial resistance (AMR) in low-resource settings.

Approach:
  • Diagnostic Platform Development: David Roach and his team are creating a low-cost, portable diagnostic platform designed for low-resource environments, focusing on ease of use, affordability, and minimal infrastructure requirements.
  • Key Considerations: The design process considers low per-test costs, minimal infrastructure, and alignment with local healthcare needs and clinical use cases.
  • Collaboration and Advocacy: Building partnerships with diagnostic technology developers and engaging with funders are essential for bridging diagnostic gaps in low-resource settings.
Key Findings:
  • The BADLOCK platform is significantly cheaper than existing diagnostic systems for AMR detection.
  • Successful diagnostics must balance innovation with usability to ensure effective implementation.
  • There is a pressing need for affordable diagnostics that can be deployed across diverse healthcare settings.
Interpretation:

Limitations:
  • The platform is still in the prototype stage and not yet widely implemented.
  • Implementation success depends on local healthcare infrastructure and resources.
Conclusion:

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.